Request Deal Involvement
BioNTech to acquire CureVac for $1.25bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Covington & Burling
legal advisors
Loyens & Loeff
financial advisors
PJT Partners
legal advisors
Hengeler Mueller
legal advisors to financial advisors
Latham & Watkins
legal advisors
NautaDutilh
legal advisors
Skadden Arps Slate Meagher & Flom
financial advisors
Goldman Sachs
legal advisors to financial advisors
Sullivan & Cromwell
or
Principals
bidder
BIONTECH
target
CUREVAC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite